MARKET

BNTC

BNTC

Benitec
NASDAQ

Real-time Quotes | Nasdaq Last Sale

3.700
+0.230
+6.63%
Closed 16:00 04/02 EDT
OPEN
3.800
PREV CLOSE
3.470
HIGH
4.000
LOW
3.666
VOLUME
2.70K
TURNOVER
--
52 WEEK HIGH
21.80
52 WEEK LOW
2.760
MARKET CAP
59.44M
P/E (TTM)
-7.4672
1D
5D
1M
3M
1Y
5Y

EPS

BNTC News

More
  • Benitec Announces Supreme Court of Queensland Approval for Redomicile
  • PR Newswire · 3d ago
  • Benitec Announces Results of Scheme Meeting
  • PR Newswire · 03/26 14:44
  • The Daily Biotech Pulse: NY State Endorses Mallinckrodt's Opioid Settlement, Kamada To Work On COVID-19 Treatment
  • Benzinga · 03/11 12:05
  • The Daily Biotech Pulse: Mesoblast To Test Candidate On Coronavirus Symptoms, Proxy Battle Ahead For Rockwell Medical, Glaukos to Join S&P SmallCap 600 Index
  • Benzinga · 03/10 13:19

Industry

Biotechnology & Medical Research
+3.32%
Pharmaceuticals & Medical Research
+2.80%

Hot Stocks

Symbol
Price
%Change

About BNTC

Benitec Biopharma Limited is a biotechnology company. The Company is engaged in progressing programs through the clinic; the commercialization of its Intellectual Property (IP); development of its therapeutic pipeline and pre-clinical programs, and funding, and protecting and building the IP estate. Its In-house product candidates include TT-034, BB-HB-331, BB-AMD-211 and ddRNAi therapeutic. It is focused on commercialization by licensing and partnering of patents and licenses in biotechnology, in functional genomics, with applications in biomedical research and human therapeutics. It has a pipeline of in-house and partnered therapeutic programs based on its patented gene-silencing technology, deoxyribonucleic acid (DNA)-directed ribonucleic acid interference (ddRNAi). The Company is engaged in developing treatments for chronic human conditions, such as hepatitis B, wet age-related macular degeneration (AMD), and oculopharyngeal muscular dystrophy (OPMD) based on this technology.
More

Webull offers kinds of Benitec Biopharma Ltd stock information, including NASDAQ:BNTC real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BNTC stock news, and many more online research tools to help you make informed decisions.